UK markets closed

Evotec SE (EVT.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
8.58-0.20 (-2.28%)
At close: 09:52PM CEST
Full screen
Previous close8.78
Open8.74
Bid8.33 x 145200
Ask8.83 x 140700
Day's range8.55 - 8.74
52-week range7.32 - 24.36
Volume250
Avg. volume442
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date14 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease

    CENTOGENE to receive license fee providing Evotec with R&D license to complete next phase of pre-clinical researchCompanies amend existing drug discovery partnership for Evotec to lead continued development. Upon Evotec exercising its option, CENTOGENE to receive an option exercise fee and other potential milestone payments and royalties CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 14, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-dr

  • Insider Monkey

    Evotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript

    Evotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript April 24, 2024 Evotec SE misses on earnings expectations. Reported EPS is $-0.05 EPS, expectations were $-0.03333. Evotec SE isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, welcome to […]

  • Simply Wall St.

    Evotec SE (ETR:EVT) Yearly Results: Here's What Analysts Are Forecasting For This Year

    One of the biggest stories of last week was how Evotec SE ( ETR:EVT ) shares plunged 32% in the week since its latest...